AstraZeneca limits access to cancer drug Iressa

WASHINGTON (Reuters) - AstraZeneca Plc's lung cancer drug Iressa will no longer be available to new patients after mid-September unless they enroll in a clinical trial, the company said on Friday.

Continue to AstraZeneca limits access to cancer drug Iressa on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz